StonvexLoading…
StonvexStonvexStonvexCore line items from IVDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.28M | $6.02M | $6.50M | $4.47M |
Operating Income | $-3.23M | $-4.07M | $-4.04M | $-3.33M |
Net Income | $-3.20M | $-3.98M | $-4.14M | $-3.35M |
EPS (Diluted) | $-0.88 | $-1.81 | $-2.07 | $-0.26 |
Total Assets | $6.43M | $5.18M | $6.31M | $9.86M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.16M | $2.63M | $4.74M | $7.31M |
Free Cash Flow OCF − CapEx | Not available | $-4.42M | $-3.42M | $-5.42M |
Shares Outstanding | 5.88M | 2.02M | 2.02M | 15.07M |